A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Treatment Gaining Traction Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.
Several professionals said the demand for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.
Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.
Service Reaction and Content Removal
According to TikTok, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Trading Activities
Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home.
Within moments of joining one group, a seller shared contact information, where the majority of purchases take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Product Details and Costs
Within these communities, messages display black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how long a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to possibly serious health risks”.
